GlaxoSmithKline (GSK) has submitted an application seeking approval from the European Medicines Agency (EMA) of a variation for Votrient (pazopanib). The approval is for additional indication for Votrient as the maintenance treatment of ...
Ensemble Therapeutics has entered into two-part research and development collaboration with Novartis for oral, macrocyclic inflammatory cytokine IL-17 antagonists and additional disease targets. The collaboration will leverage Ensemble's ...
Tags: Ensemble Therapeutics, Novartis
British drugmaker GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for its cervical cancer vaccine, Cervarix [Human papillomavirus bivalent (types 16 and 18) vaccine, ...
Tags: Cervarix, Schedule Application
Consumer Prices for July 2013 National Bureau of Statistics of China 2013-08-09 13:20:50 In July, the consumer price index (CPI) went up by 2.7 percent year-on-year. The prices grew by 2.6 percent in cities and 2.9 percent in rural areas. ...
Tags: china, economy, Consumer Prices
Total Retail Sales of Consumer Goods in July 2013 National Bureau of Statistics of China 2013-08-09 15:54:20 In July 2013, the total retail sales of consumer goods reached 1,851.3 billion yuan, up by 13.2 percent year-on-year (nominal ...
MeadWestvaco Corp. (MWV), a global leader in packaging and packaging solutions, introduced Shellpak Renew with OptilockT technology. This smaller, more discreet medication adherence package is designed to meet patient and pharmacist needs ...
Tags: Packaging
British drug maker GSK is set to open its individual patient data pertaining to the clinical trials of an array of medicines, which will enable researchers to leverage them in their specific scientific purposes. The drug company, which ...
Tags: Clinical Trials, GSK
German pharma and chemical firm Bayer has reported a net profit of €841m for the second quarter of 2013, with an increase of 74.8% compared to €481m during the comparable period earlier year. The increase in profit is primarily ...
Tags: chemical firm, Bayer
US generics drug maker Actavis has rolled out new formulations of Fioricet (butalbital, acetaminophen and caffeine capsules, USP) and Fioricet with Codeine (butalbital, acetaminophen, caffeine and codeine phosphate, USP). Both medicines ...
From January to June, the industrial profits of enterprises above designated size achieved 2,583.66 billion yuan, an increase of 11.1 percent over the same period last year, 1.2 percentage points lower than that in the first five months. Of ...
Tags: Industrial Profits
Swiss drugmaker Novartis has announced that once-daily dual bronchodilator, Ultibro Breezhaler (QVA149), has achieved positive CHMP opinion for the treatment of chronic obstructive pulmonary disease (COPD). Ultibro Breezhaler was ...
Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...
Tags: Therapies, CHMP Opinion
Eli Lilly and Company has reported 31% increase in net income to $1.21bn, or $1.11 per diluted share, for the second quarter ended on 30 July 2013, compared to $923.6m, or $0.83, for the same period last year. Increase in net income and ...
For the first time, SCHOTT Pharmaceutical Systems will be exhibiting at Interphex Japan as an expert on high-quality pharmaceutical tubing. With around 1,000 exhibitors, Interphex is one of the biggest trade shows worldwide for the ...
Tags: Schott, Interphex Japan
The US Food and Drug Administration (FDA) has dispatched warning letters to 15 firms, including foreign and domestic to desist from selling their illegally marketed diabetes products. The latest move will help the regulator to curb the ...
Tags: Diabetes'Medicines, active pharma